Crohn's Disease and Colitis Trial, Recruiting (NCT01882205)

Crohn's Disease and Colitis Trial, Recruiting NCT01882205 Sponsor: Universitaire Ziekenhuizen KU Leuven Condition: Crohn's Disease and Colitis

Printed from Voxsanity (voxsanity.com.au) — NCT01882205 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Crohns Disease And Colitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have had ulcerative colitis (a type of inflammatory bowel disease) for a long time — specifically, at least 8 years if the whole colon is affected, or at least 10 years if only the left side of the colon is affected
People who have signed a form agreeing to take part in the trial
People who have had a surveillance bowel examination (a check-up procedure using a camera) more than 1 year ago

Who may not be able to join:

People whose ulcerative colitis is currently active and affects an area more than 20 cm from the back passage (confirm with trial site)
People who have previously been diagnosed with bowel (colorectal) cancer
People who are allergic or have a known intolerance to a dye called methylene blue, which is used during the procedure
People who are unable or unwilling to give their agreement to take part in the trial
People under 18 years of age
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Raf Bisschops, MD PhD, Universitaire Ziekenhuizen KU Leuven

Phone: +3216341601

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT01882205

Sponsor: Universitaire Ziekenhuizen KU Leuven

Phase: Not Applicable

Status: Recruiting

Condition: Crohn's Disease and Colitis

Trial contact: +3216341601

More information: https://clinicaltrials.gov/study/NCT01882205

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have had ulcerative colitis (a type of inflammatory bowel disease) for a long time — specifically, at least 8 years if the whole colon is affected, or at least 10 years if only the left side of the colon is affected
People who have signed a form agreeing to take part in the trial
People who have had a surveillance bowel examination (a check-up procedure using a camera) more than 1 year ago

Who may not be able to join:

People whose ulcerative colitis is currently active and affects an area more than 20 cm from the back passage (confirm with trial site)
People who have previously been diagnosed with bowel (colorectal) cancer
People who are allergic or have a known intolerance to a dye called methylene blue, which is used during the procedure
People who are unable or unwilling to give their agreement to take part in the trial
People under 18 years of age
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Universitaire Ziekenhuizen KU Leuven

Registry

ClinicalTrials.gov

Start date

1 May 2008

Est. completion

1 December 2018

Where this trial is recruiting

🇧🇪 Belgium 🇨🇦 Canada 🇩🇰 Denmark 🇳🇱 Netherlands

Primary endpoints

The difference in total number of neoplastic lesions detected by chromoendoscopy and virtual chromoendoscopy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov